Literature DB >> 16696058

Relation between deletion of chromosome 1p36 and DNA ploidy in breast carcinoma: an interphase cytogenetic study.

F Farabegoli1, N Baldini, D Santini, C Ceccarelli, M Taffurelli, D Treré, M Derenzini.   

Abstract

Aims-To investigate whether deletion of the 1p36 region of chromosome 1 is independent of DNA ploidy in breast cancer cells.Methods-Preparations of nuclei from 64 fresh primary breast tumours were studied using dual target fluorescence in situ hybridisation (FISH) combining probes specific for the 1q12 (pUC 1.77) and 1p36 (1p-79) regions of chromosome 1. Signals were counted in 100-300 nuclei and the percentage of cells showing fewer p1-79 than pUC 1.77 signals was measured in each sample. DNA ploidy was investigated by cytofluorimetry in 55 tumour samples.Results-Chromosome 1 aberrations were detected in 56 samples. There were fewer p1-79 than pUC 1.77 signals in 53 samples. The 1p36 region was deleted in 11 samples in which a single p1-79 signal was detected; seven of these samples were diploid. Abnormalities were found in 17/24 diploid and 30/31 aneuploid tumours.Conclusions-Chromosome 1 aberrations, including deletion of the 1p36 region, were observed in diploid breast tumours. Deletion of the 1p36 region may be an early event in tumorigenesis. Given the frequency and importance of chromosome 1 aberrations in the biological behaviour of breast tumours, FISH, used in conjunction with cytofluorimetry, may be helpful for determining prognosis in patients with diploid tumours.

Entities:  

Year:  1996        PMID: 16696058      PMCID: PMC408029          DOI: 10.1136/mp.49.2.m98

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN: 1355-2910


  31 in total

1.  Cytogenetic features of twenty-six primary breast cancers.

Authors:  P J Hainsworth; K L Raphael; R G Stillwell; R C Bennett; O M Garson
Journal:  Cancer Genet Cytogenet       Date:  1991-06

Review 2.  Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes.

Authors:  B Dutrillaux; M Gerbault-Seureau; B Zafrani
Journal:  Cancer Genet Cytogenet       Date:  1990-10-15

3.  Breast cancer genetic evolution: I. Data from cytogenetics and DNA content.

Authors:  B Dutrillaux; M Gerbault-Seureau; Y Remvikos; B Zafrani; M Prieur
Journal:  Breast Cancer Res Treat       Date:  1991-11       Impact factor: 4.872

Review 4.  Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference.

Authors:  D W Hedley; G M Clark; C J Cornelisse; D Killander; T Kute; D Merkel
Journal:  Cytometry       Date:  1993

5.  Clinical impact of chromosome 1 aberrations in neuroblastoma: a metaphase and interphase cytogenetic study.

Authors:  H Christiansen; J Schestag; N M Christiansen; K H Grzeschik; F Lampert
Journal:  Genes Chromosomes Cancer       Date:  1992-09       Impact factor: 5.006

6.  Cloning of human satellite III DNA: different components are on different chromosomes.

Authors:  H J Cooke; J Hindley
Journal:  Nucleic Acids Res       Date:  1979-07-25       Impact factor: 16.971

7.  Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: interphase cytogenetics combining a centromeric, telomeric, and library DNA probe.

Authors:  P J Poddighe; F C Ramaekers; A W Smeets; G P Vooijs; A H Hopman
Journal:  Cancer Res       Date:  1992-09-15       Impact factor: 12.701

8.  Rearrangement of chromosome 1p in breast cancer correlates with poor prognostic features.

Authors:  P J Hainsworth; K L Raphael; R G Stillwell; R C Bennett; O M Garson
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

9.  DNA index, S-phase fraction, histological grade and prognosis in breast cancer.

Authors:  S M O'Reilly; R S Camplejohn; D M Barnes; R R Millis; D Allen; R D Rubens; M A Richards
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

10.  Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer.

Authors:  P D Stanton; T G Cooke; S J Oakes; J Winstanley; S Holt; W D George; G D Murray
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.